Votorantim Cimentos might have inconsistent accounting, while Gogo could be losing market share making these IPOs less desirable.
Biotech IPOs that have relationships with established drug companies will do better than those going it alone.
Technician Mark Newton sees the choppy actions of stocks in this short term downward trend, but stocks may lift heading into July.
Microsoft has made its iconic Office software available on iPhones and iPods as of today. Call it Office Lite.
Upgrades for Groupon and Solar City don't sway the market higher. Even Smith & Wesson can't shoot stocks higher on its strong results.
Stocks got a lift from economic data, but Ben Willis of Albert Fried points to rising mortgage rates as a sign the Fed is backing off.
Google is more interested in Waze's social interaction, not necessarily the traffic updates.
Travel expert Jenny McIver describes how business people can achieve the dream trip of going around the world in just 30 days.
U.S. stocks follow the Japanese stocks lower as Gannett grows its TV empire, Pfizer gets a payoff and Blackberry gets an upgrade.
Are consumers having burger fatigue? TheStreet's Laurie Kulikowski and Debra Borchardt say opportunity exists in the gourmet burger niche.